Bio-Techne Agrees to Buy Texas Testing Company for Up to $320M
Bio-Techne’s Minneapolis headquarters building Bio-Techne's website Bio-Techne Agrees to Buy Texas Testing Company for Up to $320M Bio-Techne will pay an initial $215 million in cash, with the potential to up the price by $105 million if the company hits “certain future milestones.” Bio-Techne’s Minneapolis headquarters building Bio-Techne's website Minneapolis-based life sciences firm Bio-Techne Corp. on Wednesday said it’s reached a deal to buy Austin, Texas-based Asuragen for up to $320 million. Under the terms of the dea...
Source: tcbmag.com